Telmisartan in daily clinical practice: factors affecting efficacy in treatment of primary arterial hypertension.
J Postgrad Med
;
2009 Jan-Mar; 55(1): 27-32
Artigo
em Inglês
| IMSEAR
| ID: sea-116998
ABSTRACT
BACKGROUND:
Telmisartan provides effective treatment of hypertension in a broad spectrum of patients.Aims:
To evaluate factors affecting the efficacy of telmisartan in daily clinical practice. SETTING ANDDESIGN:
Prospective practice-based 12-week uncontrolled cohort study. MATERIALS ANDMETHODS:
Consecutive incident/prevalent outpatients with mild to moderate essential hypertension were started on telmisartan 40 mg/day with optional up-titration to 80 mg/day in order to achieve seated systolic (SSBP) and diastolic (SDBP) blood pressure < 140/90 mm Hg. Intent-to-treat (ITT, N=282) and per protocol (PP, N=275) efficacy assessment was based on SSBP/SDBP reduction and delivered doses.RESULTS:
SSBP/SDBP decreased (165.2+/-13.1 / 98.3+/-6.7 mm Hg to 137.9+/-13.2 / 82.6+/-7.3 mm Hg), whilst telmisartan was up-titrated in 40.5% of patients during the study. Multivariate (practically identical ITT and PP) analysis indicated poorer response in obese vs. non-obese patients lesser SDBP reduction (by around 2.2-2.3 mm Hg, P < 0.05) with higher odds of dose up-titration (odds ratio, OR around 1.90, P < 0.05); and better response in a) patients started on telmisartan monotherapy than when added to a preexisting treatment greater SSBP/SDBP reduction (by around 4.0 and 3.0 mm Hg, respectively, P < 0.05) with comparable odds of up-titration; b) diabetics vs. non-diabetics greater SDBP reduction (by around 3.6-3.7 mm Hg, P < 0.05) with comparable odds of up-titration; c) men vs. women slightly greater SDBP reduction (by around 1.2 mm Hg, 0.05 P < 0.1) with lower odds of up-titration (OR around 0.51, P < 0.05).CONCLUSION:
Previous unsuccessful treatment, obesity, diabetes and gender should be considered in order to optimize the use of telmisartan for mild to moderate essential hypertension in daily clinical practice.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Artérias
/
Benzimidazóis
/
Benzoatos
/
Pressão Sanguínea
/
Idoso de 80 Anos ou mais
/
Idoso
/
Feminino
/
Humanos
/
Masculino
/
Análise Multivariada
Tipo de estudo:
Ensaio Clínico Controlado
/
Estudo de etiologia
/
Guia de Prática Clínica
/
Estudo observacional
/
Fatores de risco
Limite:
Aged80
Idioma:
Inglês
Revista:
J Postgrad Med
Ano de publicação:
2009
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS